5/13/22 17:19 | 5/12/22 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -1,891 | 49.41 | 0 | -38 | -32 | 80 | D | | | | | | | | | | | | | | |
11/30/21 16:30 | 11/26/21 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -2,175 | 54.37 | 0 | -40 | -37 | 68 | D | | | | | | | | | | | | | | |
5/1/20 15:56 | 4/29/20 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -2,460 | 37.85 | 0 | -65 | -45 | 80 | D | | | | | | | | | | | | | | |
2/1/19 19:21 | 1/30/19 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S.m | -1,812 | 41.37 | 0 | -44 | -51 | 42 | D | | | | | | | | | | | | | | |
3/14/18 17:13 | 3/13/18 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -1,844 | 36.89 | 0 | -50 | -37 | 85 | D | | | | | | | | | | | | | | |
3/3/17 16:06 | 3/2/17 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -693 | 34.66 | 33 | -20 | -19 | 85 | D | 7 | 19 | 1 | 9 | 10 | 7 | 3 | 1 | 0 | -1 | -1 | | | |
5/5/16 17:29 | 5/4/16 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -1,001 | 33.69 | 33 | -30 | -23 | 98 | D | 19 | 1 | -3 | 13 | 11 | 2 | 1 | 2 | 0 | 0 | 4 | 7 | -6 | |
9/18/13 16:27 | 9/16/13 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S.d | -1,748 | 28.70 | 33 | -61 | -40 | 91 | D | 67 | 22 | 4 | -2 | -2 | 2 | 1 | 1 | -1 | -1 | 3 | 5 | 11 | 8 |
3/14/13 17:52 | 3/13/13 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -420 | 28.00 | 33 | -15 | -14 | 89 | D | 56 | 35 | 18 | 11 | 2 | 2 | 1 | -1 | 0 | 1 | 9 | 2 | 4 | 14 |
11/21/12 13:07 | 11/21/12 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -291 | 24.28 | 33 | -12 | -12 | 91 | D | 56 | 30 | 10 | 2 | -4 | -1 | 0 | 3 | 0 | 2 | 5 | 14 | 22 | 36 |
5/11/12 13:41 | 5/11/12 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -450 | 22.88 | 33 | -20 | -15 | 108 | D | 47 | 15 | 16 | 9 | 3 | 2 | 1 | 3 | -1 | -1 | -3 | 6 | 8 | 33 |
8/30/11 10:19 | 8/29/11 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -170 | 18.90 | 33 | -9 | -7 | 115 | D | 22 | 24 | 1 | -11 | -4 | 7 | 7 | 3 | 0 | -1 | -7 | 2 | 14 | 31 |
8/24/11 07:55 | 8/23/11 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -54 | 18.00 | 33 | -3 | -2 | 124 | D | 18 | 20 | -1 | -10 | -8 | 1 | 2 | 3 | 1 | 4 | -4 | 5 | 18 | 35 |
5/31/11 12:00 | 5/27/11 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lankler Douglas M | NY | O | EVP | S | -158 | 20.90 | 33 | -8 | -8 | 90 | D | 49 | 43 | 30 | 10 | 3 | 3 | -1 | 2 | 2 | -1 | -2 | -12 | -10 | 10 |